These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 26908079)
1. Identification and characterization of major cat allergen Fel d 1 mimotopes on filamentous phage carriers. Luzar J; Molek P; Šilar M; Korošec P; Košnik M; Štrukelj B; Lunder M Mol Immunol; 2016 Mar; 71():176-183. PubMed ID: 26908079 [TBL] [Abstract][Full Text] [Related]
2. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction. Curin M; Weber M; Thalhamer T; Swoboda I; Focke-Tejkl M; Blatt K; Valent P; Marth K; Garmatiuk T; Grönlund H; Thalhamer J; Spitzauer S; Valenta R Clin Exp Allergy; 2014 Jun; 44(6):882-94. PubMed ID: 24552249 [TBL] [Abstract][Full Text] [Related]
3. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. Niespodziana K; Focke-Tejkl M; Linhart B; Civaj V; Blatt K; Valent P; van Hage M; Grönlund H; Valenta R J Allergy Clin Immunol; 2011 Jun; 127(6):1562-70.e6. PubMed ID: 21411130 [TBL] [Abstract][Full Text] [Related]
4. The major cat allergen, Fel d 1, in diagnosis and therapy. Grönlund H; Saarne T; Gafvelin G; van Hage M Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127 [TBL] [Abstract][Full Text] [Related]
5. Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen. Satyaraj E; Wedner HJ; Bousquet J Allergy; 2019 Oct; 74 Suppl 107(Suppl 107):5-17. PubMed ID: 31498459 [TBL] [Abstract][Full Text] [Related]
6. Biopanning for the characterization of allergen mimotopes. Pali-Schöll I; Jensen-Jarolim E Methods Mol Med; 2008; 138():271-83. PubMed ID: 18612616 [TBL] [Abstract][Full Text] [Related]
7. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy. Schmitz N; Dietmeier K; Bauer M; Maudrich M; Utzinger S; Muntwiler S; Saudan P; Bachmann MF J Exp Med; 2009 Aug; 206(9):1941-55. PubMed ID: 19667059 [TBL] [Abstract][Full Text] [Related]
8. Rational design of hypoallergens applied to the major cat allergen Fel d 1. Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990 [TBL] [Abstract][Full Text] [Related]
9. Li J; Yang L; Wang J; Yang Y; Wu Y; Jiang Q; Yang Y; Ma D; Zhang R; Huang N; Li W; Liu G; Zhu R J Immunol; 2019 Jul; 203(1):31-38. PubMed ID: 31092638 [No Abstract] [Full Text] [Related]
10. Phage display peptide libraries in molecular allergology: from epitope mapping to mimotope-based immunotherapy. Luzar J; Štrukelj B; Lunder M Allergy; 2016 Nov; 71(11):1526-1532. PubMed ID: 27341497 [TBL] [Abstract][Full Text] [Related]
11. IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice. Ganglberger E; Grünberger K; Wiedermann U; Vermes M; Sponer B; Breiteneder H; Scheiner O; Boltz G; Jensen-Jarolim E Int Arch Allergy Immunol; 2001; 124(1-3):395-7. PubMed ID: 11307026 [TBL] [Abstract][Full Text] [Related]
12. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. Worm M; Lee HH; Kleine-Tebbe J; Hafner RP; Laidler P; Healey D; Buhot C; Verhoef A; Maillère B; Kay AB; Larché M J Allergy Clin Immunol; 2011 Jan; 127(1):89-97, 97.e1-14. PubMed ID: 21211644 [TBL] [Abstract][Full Text] [Related]
13. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy. Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411 [TBL] [Abstract][Full Text] [Related]
14. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects. Mark PG; Segal DB; Dallaire ML; Garman RD Clin Exp Allergy; 1996 Nov; 26(11):1316-28. PubMed ID: 8955581 [TBL] [Abstract][Full Text] [Related]
15. Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy. Ganglberger E; Barbara Sponer ; Schöll I; Wiedermann U; Baumann S; Hafner C; Breiteneder H; Suter M; Boltz-Nitulescu G; Scheiner O; Jensen-Jarolim E FASEB J; 2001 Nov; 15(13):2524-6. PubMed ID: 11641259 [TBL] [Abstract][Full Text] [Related]
16. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565 [TBL] [Abstract][Full Text] [Related]
17. Fel d 4, a cat lipocalin allergen. Smith W; Butler AJ; Hazell LA; Chapman MD; Pomés A; Nickels DG; Thomas WR Clin Exp Allergy; 2004 Nov; 34(11):1732-8. PubMed ID: 15544598 [TBL] [Abstract][Full Text] [Related]
18. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine. Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402 [TBL] [Abstract][Full Text] [Related]
19. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. Reefer AJ; Carneiro RM; Custis NJ; Platts-Mills TA; Sung SS; Hammer J; Woodfolk JA J Immunol; 2004 Mar; 172(5):2763-72. PubMed ID: 14978075 [TBL] [Abstract][Full Text] [Related]
20. A novel IgE-binding epitope of cat major allergen, Fel d 1. Tasaniyananda N; Tungtrongchitr A; Seesuay W; Sakolvaree Y; Indrawattana N; Chaicumpa W; Sookrung N Biochem Biophys Res Commun; 2016 Feb; 470(3):593-598. PubMed ID: 26797272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]